Acelyrin, Inc. (SLRN)
NASDAQ: SLRN · IEX Real-Time Price · USD
+0.190 (4.39%)
May 22, 2024, 4:00 PM EDT - Market closed

Acelyrin Statistics

Total Valuation

Acelyrin has a market cap or net worth of $447.60 million. The enterprise value is -$229.80 million.

Market Cap 447.60M
Enterprise Value -229.80M

Important Dates

The last earnings date was Monday, May 13, 2024, after market close.

Earnings Date May 13, 2024
Ex-Dividend Date n/a

Share Statistics

Acelyrin has 99.03 million shares outstanding. The number of shares has increased by 377.81% in one year.

Shares Outstanding 99.03M
Shares Change (YoY) +377.81%
Shares Change (QoQ) +39.38%
Owned by Insiders (%) 8.06%
Owned by Institutions (%) 106.91%
Float 63.90M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.69
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 13.27, with a Debt / Equity ratio of 0.00.

Current Ratio 13.27
Quick Ratio n/a
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -33.90% and return on invested capital (ROIC) is -50.37%.

Return on Equity (ROE) -33.90%
Return on Assets (ROA) -31.20%
Return on Capital (ROIC) -50.37%
Revenue Per Employee n/a
Profits Per Employee -$4.71M
Employee Count 51
Asset Turnover n/a
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -78.28% in the last 52 weeks.

Beta (1Y) n/a
52-Week Price Change -78.28%
50-Day Moving Average 5.59
200-Day Moving Average 9.84
Relative Strength Index (RSI) 40.54
Average Volume (30 Days) 1,186,366

Short Selling Information

The latest short interest is 8.53 million, so 8.61% of the outstanding shares have been sold short.

Short Interest 8.53M
Short Previous Month 7.85M
Short % of Shares Out 8.61%
Short % of Float 13.34%
Short Ratio (days to cover) 8.64

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -325.01M
Pretax Income -240.16M
Net Income -240.16M
EBITDA -239.81M
EBIT -240.16M
Earnings Per Share (EPS) -$2.38
Full Income Statement

Balance Sheet

The company has $678.54 million in cash and $1.13 million in debt, giving a net cash position of $677.40 million or $6.84 per share.

Cash & Cash Equivalents 678.54M
Total Debt 1.13M
Net Cash 677.40M
Net Cash Per Share $6.84
Equity / Book Value 644.07M
Book Value Per Share 6.50
Working Capital 641.70M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$201.68 million and capital expenditures $4.89 million, giving a free cash flow of -$196.79 million.

Operating Cash Flow -201.68M
Capital Expenditures 4.89M
Free Cash Flow -196.79M
FCF Per Share -$2.01
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Acelyrin does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -377.81%
Shareholder Yield -377.81%
Earnings Yield -53.66%
FCF Yield -43.96%

Analyst Forecast

The average price target for Acelyrin is $22.00, which is 386.73% higher than the current price. The consensus rating is "Buy".

Price Target $22.00
Price Target Difference 386.73%
Analyst Consensus Buy
Analyst Count 7
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -26.06%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


Altman Z-Score n/a
Piotroski F-Score 3